The Division of Molecular Medicine focuses on the manipulation of genes and proteins to create novel therapies for inherited disorders and acquired and infectious diseases. Current projects include:
Studies of the mechanism and control of processes critical to antigen-receptor diversity in Fredrick Alt's laboratory.
Studies of the structures of viral proteins that mediate entry into cells in Stephen Harrison's laboratory.
Investigations of the feasibility of gene transfer for treating certain inherited diseases involving hematopoietic cells and for anti-cancer therapies targeting the tumor vasculature in Richard Mulligan's laboratory.
Featured researchers in the Division of Molecular Medicine hold faculty appointments at Harvard Medical School.
